Cancer Research UK logo.
SearchDonate
  • Search
Researcher doing a presentation.

How we deliver research

We invest nearly £400m annually into cancer research. This investment spans funding, conferences, international partnerships and initiatives, and supports our research network and infrastructure.

Our approach

We're at the forefront of the global fight against cancer, working with incredible researchers and partners across the world to achieve our ambitious vision for a better future.

Our research priorities

Our strategy shapes how we'll discover more about the mechanisms of how cancer develops and progresses to unlock new and better ways to prevent, detect and treat it.

How we review funding

Our funding process is supported by an exceptional peer review network, expert panels and committees. With their support, we can identify and support the highest-quality cancer research with the greatest potential to make an impact for people affected by cancer.

Strategic research partnerships

We partner with organisations ranging from small cancer specific charities to large multi-national research funders. Together we can accelerate progress and make a real difference for people affected by cancer.

Equality, diversity and inclusion in research

Our equality, diversity and inclusion (EDI) in research action plan lays out how we’re creating an inclusive and diverse community and tackling systemic issues like underrepresentation and racial bias through the research we fund.

Involving patients in our research

We want our research to be as impactful as possible. To achieve this, we’re committed to involving people affected by cancer in our work and in the research that we fund. 

Our infrastructure

Researchers working in the lab.

Our centres, institutes and national network

Our long-term investment in critical infrastructure has helped create a thriving network of research across the UK. These facilities provide research and translational capabilities and support close partnerships with universities and the NHS.

A man being pushed in a wheelchair by a doctor.

Centre for Drug Development

Our Centre for Drug Development (CDD) partners with biotechs, pharmaceutical companies and academics world-wide to deliver early-phase clinical trials, accelerating the next generation of cancer treatments to patients.

Researcher looking at a cell image.

Cancer Research Horizons

Cancer Research Horizons is our translational arm. It works closely with researchers, industry partners and investors to translate cutting-edge innovations into new tools, treatments and diagnostics for people affected by cancer.

Stay connected